Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow

被引:27
作者
Matthes, T. [1 ]
Manfroi, B. [2 ]
Zeller, A. [3 ]
Dunand-Sauthier, I. [3 ]
Bogen, B. [4 ]
Huard, B. [1 ,2 ,3 ]
机构
[1] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland
[2] Univ Grenoble 1, Analyt Immunol Chron Pathol, Albert Bonniot Inst, INSERM, Grenoble, France
[3] Fac Med, Dept Pathol & Immunol, Geneva, Switzerland
[4] Univ Hosp, Inst Immunol, Oslo, Norway
关键词
PRECURSOR CELLS; INTERLEUKIN-6; GROWTH; DIFFERENTIATION; EXPRESSION; APRIL; PROGENITORS; ANTIBODIES; APOPTOSIS; SURVIVAL;
D O I
10.1038/leu.2015.145
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Multiple myeloma (MM) invariably develops in the bone marrow (BM), indicating the strong requirement of this tumor for the peculiar BM microenvironment, rich in cytokine and hematopoietic precursor cells. Interleukin-6 (IL-6) and a proliferation inducing ligand (APRIL) are key cytokines implicated in MM development. Here, we show that MM cells changed the hematopoietic microenvironment early upon BM infiltration by strongly downregulating hematopoietic precursor cells from all lineages except myeloid precursor cells. Myeloid precursor cells constituted a major source of APRIL in MM-infiltrated BM, and their proliferative response to IL-6 upregulation explained their relative resistance to MM infiltration. The osteolytic molecule receptor activator of NFkB ligand (RANK-L) expressed by MM cells started this myeloid proliferation by inducing in a contact-dependent manner IL-6 production by myeloid precursor cells themselves. Taken together, our data demonstrate that MM cells do not simply displace hematopoietic cells upon BM infiltration, but rather selectively modulate the BM microenvironment to preserve a pool of high APRIL-producing myeloid precursor cells. Our data also identify a positive regulation of APRIL by IL-6 in myeloid precursor cells.
引用
收藏
页码:1882 / 1890
页数:9
相关论文
共 35 条
[31]  
UCHIYAMA H, 1993, BLOOD, V82, P3712
[32]  
van Zaanen HCT, 1998, BRIT J HAEMATOL, V102, P783
[33]   Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop [J].
vanZaanen, HCT ;
Koopmans, RP ;
Aarden, LA ;
Rensink, HJAM ;
Stouthard, JML ;
Warnaar, SO ;
Lokhorst, HM ;
vanOers, MHJ .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (06) :1441-1448
[34]   Effects of organ-specific loss of insulin-like growth factor-I production on murine hematopoiesis [J].
Welniak, LA ;
Karas, M ;
Yakar, S ;
Anver, MR ;
Murphy, WF ;
LeRoith, D .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (01) :32-39
[35]   Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches [J].
Wong, David ;
Winter, Oliver ;
Hartig, Christina ;
Siebels, Svenja ;
Szyska, Martin ;
Tiburzy, Benjamin ;
Meng, Lingzhang ;
Kulkarni, Upasana ;
Faehnrich, Anke ;
Bommert, Kurt ;
Bargou, Ralf ;
Berek, Claudia ;
Van Trung Chu ;
Bogen, Bjarne ;
Jundt, Franziska ;
Manz, Rudolf Armin .
PLOS ONE, 2014, 9 (10)